WA
GSK icon

Wealth Alliance’s GSK GSK Stock Holding History

Wealth Alliance’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,278
Closed -$1.09M – 568
2025
Q4 		$1.09M Sell
22,278
-5,186
-19% -$242K 0.11% 170
2025
Q3 		$1.19M Buy
27,464
+1,028
+4% +$40.2K 0.12% 154
2025
Q2 		$1.02M Buy
+26,436
New +$1.01M 0.11% 166
2020
Q4 		– Sell
-11,541
Closed -$543K – 380
2020
Q3 		$543K Sell
11,541
-1,121
-9% -$56.2K 0.2% 135
2020
Q2 		$646K Buy
12,662
+1,468
+13% +$75.3K 0.26% 98
2020
Q1 		$530K Sell
11,194
-3,931
-26% -$210K 0.29% 101
2019
Q4 		$888K Buy
+15,125
New +$841K 0.63% 43

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wealth Alliance's GSK Position: Q1 2026 in Review

Wealth Alliance sold out of GSK (GSK) in Q1 2026, closing a stake of 22,278 shares — an estimated $1.09M sold.

Wealth Alliance first reported a position in GSK in Q4 2019 and held it in 7 quarters. The position peaked at $1.19M in Q3 2025. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Wealth Alliance reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
  • Wealth Alliance sold 22,278 GSK shares in Q1 2026, an estimated $1.09M.
  • Wealth Alliance first reported a position in GSK in Q4 2019 and held it in 7 quarters.
  • Wealth Alliance's GSK position peaked at $1.19M in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Wealth Alliance's 13F filing for Q1 2026, filed 14 May 2026.